DK0790254T3 - Pseudopeptider afledt fra neurokininer, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse - Google Patents

Pseudopeptider afledt fra neurokininer, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK0790254T3
DK0790254T3 DK97400289T DK97400289T DK0790254T3 DK 0790254 T3 DK0790254 T3 DK 0790254T3 DK 97400289 T DK97400289 T DK 97400289T DK 97400289 T DK97400289 T DK 97400289T DK 0790254 T3 DK0790254 T3 DK 0790254T3
Authority
DK
Denmark
Prior art keywords
neurokinins
preparation
methods
pharmaceutical compositions
compositions containing
Prior art date
Application number
DK97400289T
Other languages
Danish (da)
English (en)
Inventor
Jean-Luc Fauchere
Nathalie Kucharczyk-Gentric
Emmanuel Canet
Michel Lonchampt
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0790254T3 publication Critical patent/DK0790254T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97400289T 1996-02-16 1997-02-10 Pseudopeptider afledt fra neurokininer, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse DK0790254T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9601919A FR2745003B1 (fr) 1996-02-16 1996-02-16 Nouveaux pseudopeptides derives de neurokinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0790254T3 true DK0790254T3 (da) 2001-10-08

Family

ID=9489264

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97400289T DK0790254T3 (da) 1996-02-16 1997-02-10 Pseudopeptider afledt fra neurokininer, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse

Country Status (16)

Country Link
US (1) US5708016A (no)
EP (1) EP0790254B1 (no)
JP (1) JPH09227554A (no)
CN (1) CN1164537A (no)
AT (1) ATE204582T1 (no)
AU (1) AU713096B2 (no)
CA (1) CA2197611A1 (no)
DE (1) DE69706206T2 (no)
DK (1) DK0790254T3 (no)
ES (1) ES2163104T3 (no)
FR (1) FR2745003B1 (no)
GR (1) GR3037045T3 (no)
NO (1) NO970676L (no)
NZ (1) NZ314238A (no)
PT (1) PT790254E (no)
ZA (1) ZA971267B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653304B2 (en) * 2000-02-11 2003-11-25 Bristol-Myers Squibb Co. Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
WO2002000646A1 (en) * 2000-06-27 2002-01-03 Smithkline Beecham Corporation Fatty acid synthase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK65094A3 (en) * 1992-09-03 1995-03-08 Boehringer Ingelheim Kg Aminoacid derivatives, process for producing the same and pharmaceutical compositions containing these derivatives
FR2719312B1 (fr) * 1994-04-28 1996-06-14 Adir Nouveau pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
NZ314238A (en) 1997-12-19
AU713096B2 (en) 1999-11-25
JPH09227554A (ja) 1997-09-02
CA2197611A1 (fr) 1997-08-17
CN1164537A (zh) 1997-11-12
ATE204582T1 (de) 2001-09-15
DE69706206D1 (de) 2001-09-27
DE69706206T2 (de) 2002-05-23
EP0790254B1 (fr) 2001-08-22
AU1266097A (en) 1997-08-21
PT790254E (pt) 2001-11-30
NO970676D0 (no) 1997-02-14
ZA971267B (en) 1997-08-27
NO970676L (no) 1997-08-18
FR2745003A1 (fr) 1997-08-22
FR2745003B1 (fr) 1998-04-03
EP0790254A1 (fr) 1997-08-20
ES2163104T3 (es) 2002-01-16
GR3037045T3 (en) 2002-01-31
US5708016A (en) 1998-01-13

Similar Documents

Publication Publication Date Title
DE69406649D1 (de) N-alkyl-2-substituierte atp-analoge
EA200100971A1 (ru) Новые соединения и композиции в качестве ингибиторов протеазы
IL128691A0 (en) Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
NO20021859D0 (no) Nye digosakkarider, deres fremstilling samt farmasöytiske preparater
ZA971183B (en) Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants.
ES2037105T3 (es) Un metodo para preparar indoloquinoxalinas sustituidas.
DE69229339D1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
DE69634961D1 (de) Neue zyklische depsipeptid pf1022 derivate
DE69323712D1 (de) Indol derivate zur behandlung von migräne
EA200301203A1 (ru) Новые соединения и композиции как ингибиторы катепсина
DK0790254T3 (da) Pseudopeptider afledt fra neurokininer, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse
DK0758312T3 (da) Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler
ATE247955T1 (de) Selenophen-antitumormittel
NO972943D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
EA200000922A1 (ru) Производные аминоантрациклинона и их применение в лечении амилоидоза
DE69724130D1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl protein transferase inhibitoren